Table 2.
Phthalate Metabolite Concentrations (ng/ml) in comparison group1, infertile women using ART, and infertile women who did not use ART in the TIDES study.
| Phthalate | Metabolite | Percent above LOD2 | Comparison Group1 (n=402) | Women using ART (n=41) | Infertile not using ART (n=25) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Percentiles | Percentiles | Percentiles | |||||||||
| 25th | 50th | 75th | 25th | 50th | 75th | 25th | 50th | 75th | |||
| Di-2-ethylhexyl phthalate (DEHP) | Mono-2-ethylhexyl phthalate (MEHP) | 62.4 | 0.71 | 1.80 | 4.20 | 0.71 | 1.00 | 2.80 | 0.71 | 1.30 | 3.80 |
| Mono-2-ethyl-5-oxohexyl phthalate (MEOHP) | 95.9 | 1.80 | 4.00 | 8.40 | 1.50 | 3.00 | 7.00 | 1.40 | 3.00 | 9.00 | |
| Mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP) | 97.3 | 2.40 | 5.70 | 12.20 | 2.00 | 4.40 | 9.60 | 1.90 | 4.60 | 15.00 | |
| Mono-2-ethyl-5-carboxypentyl phthalate (MECCP) | 97.9 | 2.90 | 8.20 | 16.70 | 2.60 | 5.70 | 15.40 | 4.80 | 7.20 | 12.70 | |
| ΣDEHP3 | -- | 26.31 | 66.22 | 139.68 | 22.95 | 47.38 | 116.76 | 29.41 | 54.01 | 136.88 | |
| Monobenzyl phthalate (MBZP) | 83.7 | 0.80 | 2.70 | 7.00 | 0.71 | 2.00 | 5.90 | 0.71 | 1.60 | 7.00 | |
| Monoethyl phthalate (MEP) | 98.9 | 7.90 | 22.05 | 57.00 | 13.00 | 22.00 | 73.00 | 8.70 | 23.60 | 95.00 | |
| Monoisobutyl phthalate (MIBP) | 97.0 | 1.30 | 3.80 | 9.00 | 1.60 | 3.70 | 8.10 | 0.80 | 3.30 | 8.10 | |
| Mono-3-carboxypropyl phthalate (MCPP) | 72.3 | 0.71 | 1.30 | 3.90 | 0.71 | 0.80 | 3.40 | 0.71 | 1.10 | 3.00 | |
| Mono-butyl phthalate (MBP) | 91.7 | 2.00 | 6.00 | 14.50 | 2.00 | 6.00 | 10.40 | 3.00 | 5.00 | 11.00 | |
1
Women who reported no history of infertility
2
LOD=Limit of Detection
3
ΣDEHP = (MEHP/278) + (MEHHP/294) + (MEOHP/292) + (MECPP/308)) * 1000